Clinical Psychiatry News - Bupropion as adjunct to patch yields long-term results.(Addiction Psychiatry)(Clinical report)
PARIS — Enhancing a smoking cessation program with a daily dose of bupropion enabled a small group of schizophrenia patients to stay off nicotine in a randomized, placebo-controlled trial reported by Dr. Tony P. George at the annual congress of the European College of Neuropsychopharmacology.
All patients received 10 weeks of behavioral therapy during which they wore a transdermal nicotine patch 24 hours a day. In addition, 27 patients took 300 mg of bupropion SR daily, while 27 patients received a placebo.
Most Popular
3 Questions No Job Seeker Ever Wants To Be Asked?
13 Job Interview Mistakes To Avoid
Online Jobs: Stop Commuting, Work From Home
Ten Tips for Making Your Business More Efficient
The Global CFO Study 2008
At the conclusion of the intervention, 30% of the bupropion group …
Read the rest of this article with a Free Trial at HighBeam Research.
